2014
DOI: 10.1016/j.bjane.2013.10.010
|View full text |Cite
|
Sign up to set email alerts
|

A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery

Abstract: Prophylactic fibrinogen reduces post-operative bleeding in patients undergoing coronary artery bypass graft.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
1

Year Published

2015
2015
2018
2018

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 15 publications
0
19
1
Order By: Relevance
“…[16,17] Recent studies have demonstrated an association between the level of fibrinogen and postoperative blood loss, [18,19] and even suggested prophylactic supplementation of fibrinogen. [20] Similarly, in our study, the patients had critical or low fibrinogen levels; however, this study was not adequately powered to detect a difference between such low percentage change. Recent guidelines have suggested that fibrinogen levels should be >200 mg/dL for sufficient clot strength.…”
Section: Discussionmentioning
confidence: 56%
“…[16,17] Recent studies have demonstrated an association between the level of fibrinogen and postoperative blood loss, [18,19] and even suggested prophylactic supplementation of fibrinogen. [20] Similarly, in our study, the patients had critical or low fibrinogen levels; however, this study was not adequately powered to detect a difference between such low percentage change. Recent guidelines have suggested that fibrinogen levels should be >200 mg/dL for sufficient clot strength.…”
Section: Discussionmentioning
confidence: 56%
“…In general complex cardiac surgery, the same approach was followed in a recent prospective randomized double-blind study in 116 patients. 49 Also in this study, the percentage of patients avoiding all allogeneic blood products was significantly higher (67 vs. 45%) and the amounts of RBCs, Cardiac surgery (CABG) Prophylactic preoperatively 1 g Sadeghi et al 51 Cardiac surgery (valve replacement) Moderate bleeding 4 g Tanaka et al 52 Cardiac surgery (pediatric) FIBTEM A10 5 mm 20 mL/kg FFP Nakayama et al 55 Liver transplantation FIBTEM MCF 6 mm Not specified Kirchner et al 57 Liver transplantation FIBTEM MCF 6 mm or Fibrinogen < 1 g/L 50 mg/kg Roullet et al 59 Obstetric Fibrinogen < 2 g/L Not specified Abdul-Kadir et al 70 Obstetric Fibrinogen 2 g/L 4 g Ahmed et al 76…”
Section: Cardiac Surgerymentioning
confidence: 51%
“…Karlsson et al found in a small study of 20 patients that a preoperative 2 g dose of fibrinogen (vs. placebo) in patients undergoing coronary artery bypass grafting (CABG) surgery reduced postoperative blood loss and increased the Hb concentration at postoperative day 1 without effect on transfusion rate. 50 A similar approach was chosen by Sadeghi et al 51 In 60 patients undergoing CABG surgery they administered 1 g of fibrinogen (versus placebo) after anesthesia induction and found reduced postoperative bleeding. There was a trend toward fewer patients needing postoperative RBC transfusions, but the difference was not statistically significant.…”
Section: -50 Mg/kgmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of Haemocomplettan P/RiaSTAP to control bleeding and to decrease the use of allogeneic blood products during cases of acquired bleeding has been reported in a variety of clinical settings, including surgery, trauma, liver transplantation, and obstetrics. 28 30 , 33 , 36 43 Furthermore, recent systematic reviews confirm that the use of fibrinogen concentrate may reduce allogeneic blood product transfusion 44 46 ; however, very often the trials are of low quality with a high risk of bias. Moreover, the measured outcomes, such as transfusion requirements, may be prone to performance bias.…”
Section: Fibrinogen Concentrate: the Past And The Presentmentioning
confidence: 99%